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Abstract
Objective. The objective of this study was to determine whether there are significant differences in terms of indications,
techniques, patient variables, and objective and subjective outcome scores as a function of the geographic locale of
published studies of knee articular cartilage surgery. Methods. An electronic database search was performed of clinical
studies evaluating knee articular cartilage procedures from 2000 to 2021. Studies were separated into global regions
(Europe, Asia, North America, and South America) based on the study country. All cartilage-based treatments in each
region were recorded. Patient age and sex, mechanism of injury, cartilage lesion size and location, follow-up time, failure
rate, and knee outcome scores utilized were summarized and compared by region. Results. A total of 2,923 studies were
analyzed. Eighty level 1 and 2 studies met the inclusion criteria. The majority were from Europe (n = 60), followed by
Asia (n = 11), North America (n = 7), and South America (n = 2). The majority of procedures in European and North
American studies were cell-based and marrow-stimulation procedures. In Asian studies, the most common procedures
were marrow-stimulation, experimental, and biologic procedures as defined by the authors. Asian countries had a higher
proportion of females (P < 0.001) and an overall older patient population (P < 0.001). Regional variation was also seen in
terms of lesion location, mechanism of injury, and failure rate. Conclusion. Most high-level evidence for articular cartilagebased procedures of the knee comes from European countries. These studies vary by patient age and sex, anatomic
location, and mechanism of injury. Global variation should be taken into consideration when interpreting and applying
studies of knee articular cartilage surgery.
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transplant, biologic treatment, regional difference

Introduction
Articular cartilage injuries are present in 60% to 66% of
knees undergoing arthroscopy.1-4 Focal full-thickness chondral defects have a prevalence of 4.2% to 6.2% among all
patients undergoing knee arthroscopy and up to 36% in athletes.1-4 Focal articular cartilage defects can negatively
affect the lives of patients and have been shown to impair
quality of life as much as patients with severe osteoarthritis.5 Articular cartilage injuries have limited regenerative
capacity in adults, and thus, have been implied as a potential risk factor for the development of osteoarthritis.6-9
Given the limited capacity of articular cartilage defects to
heal, there has been considerable research dedicated to the
development of the optimal method to surgically treat these
lesions.8,10

Several surgical and non-surgical techniques have been
shown to be beneficial in treating articular cartilage injuries, and their success has led to an increase in the utilization of these techniques over the last 20 years.10,11 Variables
that may influence how articular cartilage defects are treated
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include patient age, activity level, lesion size, concomitant
pathology, mechanical alignment, and comorbidities.10-12
These variables have led to debate in the literature over the
optimal method to treat these injuries, which has led to an
evolution in how these lesions are managed.13,14
A variety of societal factors, particularly cultural and
economic, may influence how articular cartilage lesions are
treated in different parts of the world. Prior studies have
evaluated surgical trends for management of articular cartilage injuries within specific countries.10,15,16 However, to
our knowledge, no study has assessed the management of
these injuries as a function of global region.11,13,14 It is
important to understand regional differences as they may be
an important source of selection bias in clinical studies
evaluating the treatment of articular cartilage defects.
Economic factors may preclude certain techniques that are
more costly in favor of less expensive options. Surgeon
training and experience in some parts of the world may also
limit the number times a specific surgical technique is utilized irrespective of the perceived success of the procedure.
Finally, cultural mores or religious restrictions may prevent
the use of allograft tissue that is unique to certain populations worldwide.13,17 Therefore, the purpose of this systematic review was to determine whether differences exist in
the preferred techniques used to surgically treat articular
cartilage defects of the knee across different regions around
the globe and secondarily if there are regional differences in
patient demographics, mechanism of injury, cartilage defect
anatomical location, outcome scores utilized, and failure
rates of cartilage-based procedures. It was our hypothesis
that global variation would exist as exemplified by the published literature from different regions.

Methods
A systematic review was performed following best practices as established by the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) statement.18 An electronic search was performed on April 1,
2021, by a medical librarian using a combination of keywords and controlled vocabulary in Embase.com, Ovid
Medline, Scopus, Cochrane Central Register of Controlled
Trials (CENTRAL), and Clinicaltrials.gov. Search terms
included “articular cartilage,” “chondral injury,” “osteochondral,” “osteochondral allograft,” “osteochondral autograft,”
“autologous
chondrocyte
implantation,”
“matrix-associated chondrocyte implantation,” “microfracture,” “chondroplasty,” “stem cells,” “platelet rich plasma,”
and “bone marrow aspirate concentrate.”
Only human clinical studies published between 2000
and 2021 were considered irrespective of the primary language of the publication. A total of 2,923 results were found.
Forty-seven duplicate records were deleted after using the
de-duplication processes described in “De-duplication of
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database search results for systematic reviews in EndNote,”4
resulting in a total of 2,876 unique citations included in the
project library.
Inclusion criteria included published clinical studies
with level 1 and 2 evidence for the surgical and non-surgical
treatment of focal articular cartilage injuries of the knee
diagnosed by either magnetic resonance imaging (MRI) or
arthroscopy of all languages. Level 1 studies were highquality randomized, prospective trials with greater than
80% follow-up.19 Level 2 studies included lower-quality
randomized, prospective trials (i.e., less than 80% followup) and non-randomized prospective cohort studies.19 Level
3 to 5 studies, abstracts, case reports, studies investigating
osteoarthritis, animal studies, basic science studies, studies
evaluating post-operative rehabilitation protocols, and studies reporting techniques without meaningful data were
excluded (Figure 1). Anatomic location of the chondral
lesions, when reported, were categorized as either “femoral
condyle,” which included the medial femoral condyle
(MFC) and lateral femoral condyle (LFC), “patellofemoral,” which included the trochlea and patella, and “tibial
plateau,” which included the medial tibial plateau (MTP)
and lateral tibial plateau (LTP). Abstracts of the 2,876 articles were reviewed by 2 authors (RGS and JJG) for inclusion in the systematic review; 80 articles were found to
satisfy the inclusion and exclusion criteria.

Statistical Analysis
Each manuscript was evaluated and a summation of results
was performed based on the country of origin. Data were
extracted by 2 authors (RGS and JJG) and verified by the first
author, and any discrepancies were resolved by a third author
(RHB). The countries in which the studies were performed
were documented, and the studies were classified into 4
regions: Europe, Asia, North America, and South America.
Each specific procedure was categorized as either “cell based,”
“marrow stimulation,” “osteochondral autograft/mosaicplasty,” “biologic,” and “other/experimental” (Table 1). Age,
duration of follow-up, body mass index (BMI), and lesion size
summary statistics were all evaluated with 1-way analysis of
variance. Intergroup differences in age were evaluated with the
Student t test. Overall and intergroup differences in sex, mechanism of injury, and location of the lesion(s) were evaluated
with the chi-square test. All statistical analyses were performed
with Microsoft Excel software (Microsoft, United States).

Results
Eighty studies were included in this systematic review
(Suppl. Table S1). The majority of the studies were from
Europe, followed by Asia, North America, and South
America (Table 2). There were similar numbers of level 1
and 2 studies, with slightly more level 2 studies, overall.
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Figure 1. Flow diagram of article review.

CENTRAL = Cochrane Central Register of Controlled Trials.

The number of patients included in studies from each
respective region is shown in Table 2.

Procedures by Region
The specific types of procedures varied by global region
(Table 3). The 2 most common procedures evaluated in
European countries were cell based (66.7% of studies) and
marrow stimulation (56.7% of studies). In Asian countries,
the 3 most common procedures evaluated were marrow
stimulation (81.8% of studies), experimental (63.6% of
studies), biologic (36.4% of studies). In North America,
cell-based procedures (85.7% of studies) and marrow stimulation (42.9%) were the 2 most common treatment forms
evaluated. In South America, which included only 2 total
studies, there was an equivalent number of cell-based (50%
of studies), marrow-stimulation (50% of studies), osteochondral autograft/mosaicplasty (50% of studies), and biologic procedures (50% of studies).

Demographics by Region
Males were more commonly evaluated in all global regions
except in the Asian countries (P < 0.001) (Table 4). Mean
patient age in all studies was similar with no differences in
European (34.4 years), North American (35.7 years), and
South American (35.8 years) studies; however, studies from
Asian countries had a significantly older patient population
with an average age of 46.2 years (P < 0.001) (Table 4).
Follow-up time, BMI, and lesion size were similar between
regions (Table 4).

Anatomic Location of Chondral Defect by Region
Specific lesion location was reported in 83% of the
European studies, 63.6% of the Asian studies, 85.7% of the
North American studies, and 100% of the South American
studies. The most common anatomic locations evaluated
were femoral condyle (medial and lateral), followed by
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Table 1. Specific Procedures within Each Group.
Marrow-Stimulation
•

Microfracture

Cell-Based Treatment

Osteochondral Autograft/
Mosaicplasty

• Autologous
• Osteochondral
chondrocyte
autograft
implantation (ACI) (1st
transplantation
and 2nd generation)
• Mosaicplasty
• Matrix-induced
autologous
chondrocyte
implantation (MACI)
• Characterized
chondrocyte
implantation (CCI)
• Cartilage autograft
implantation system
(CAIS)

Biologic

Experimental

• Platelet rich plasma
• Extracellular
(PRP)
biomembrane
•• Bone marrow–derived • Hyaluronic acid ±
stem cells (BMSCs)
peripheral blood stem
cells
• Collagen-augmented
chondrogenesis
(C-ACT)
• Allogenic cartilage ±
multipotent stem cells
• Umbilical-derived stem
cells ± hyaluronic acid
• Chitosan scaffold
• Radiofrequency
ablation
• Pulsed electromagnetic
field
• Hyaluronic acid
scaffold ± bone
marrow aspirate
concentrate
• Microfragmented
Stromal Vascular
Fraction
• Autologous
matrix-induced
chondrogenesis
(AMIC) ± bone
marrow aspirate
concentrate
• Polyglycolic acid matrix
augmentation
• Matrix-induced
autologous
mesenchymal stem cell
implantation (m-AMI)

Table 2. Number of Studies by Level of Evidence from Each Region.
Level 1

Level 2

Studies

Patients

30

30

60

Asia

4

7

11

North America

2

5

7

South America

1

1

2

Level 1: 2,317
Level 2: 2,340
Level 1: 219
Level 2: 455
Level 1: 110
Level 2: 621
Level 1: 38
Level 2: 64

Europe

patellofemoral (trochlea and patella) and tibial plateau
(medial and lateral) (Table 5). Interestingly, there was significant overall and intergroup differences in lesion location
between all global regions (P < .05). For example, Asian

studies show a higher percentage of patellofemoral lesions
when compared with European, North American, and South
American studies. In addition, multiple anatomic locations
of chondral defects were noted in 20% of European studies,
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Table 3. Procedures by Region.
Cell-Based
Europe
Asia
North America
South America

MarrowStimulation

Osteochondral
Autograft/Mosaicplasty

Biologic

Experimental

Other

34
9
3
1

12
1
NA
1

4
4
NA
1

16
7
1
NA

7

40
3
6
1

NA = not applicable.

Table 4. Demographic Data by Region.
Length of Follow-Up

Age

Gender

Lesion Size

Body Mass Index

Europe

49.4 months

34.4 years

3.87 cm2

24.6

Asia

36.1 months

46.2 years

3.76 cm2

27.1

North America

38.8 months

35.7 years

3.88 cm2

25.6

South America

26.5 months

35.8 years

1.53 cm2

25.3

P = 0.98

P < 0.001

Male: 2,496
Female: 1,575
Male: 245
Female: 346
Male: 476
Female: 283
Male: 82
Female: 20
P < 0.001

P = 0.31

P = 0.06

28.6% of Asian studies, 66.7% of North American studies,
and 50% of South American studies.

Mechanism of Chondral Lesion by Region
Reporting of the mechanism of cartilage injury was poor
among all 4 global regions and was provided by 55% of
European studies, 54.5% of Asian studies, 57.1% of North
American studies, and 0% of South American studies. In
those studies that reported mechanism of cartilage injury,
both European and North American countries listed more
traumatic mechanisms (71% and 58.1%, respectively) than
Asian countries (10.3%). Asian studies reported a much
higher percentage of degenerative lesions (89.7%) than
European and North American studies (16.7% and 41.9%,
respectively). Intergroup analysis showed significant differences between each group analyzed in regard to the mechanism of cartilage injury (Table 6). Osteochondritis dissecans
(OCD) was only evaluated in studies from European
countries.

Outcome Scores Utilized by Region
The most common subjective and objective outcome measures used in the European and Asian countries were the
International Knee Documentation Committee (IKDC)
score (40% and 63.6%, respectively), Knee Injury and
Osteoarthritis Outcome Score (KOOS) (40% and 55%,
respectively), visual analog scale (VAS) (30% and 45.5%,
respectively), Tegner activity scale (30% and 27.3%,

respectively), and Lysholm knee scores (26.7% and 45.5%,
respectively). South American countries most commonly
used the IKDC (100%), VAS (50%), Tegner activity scale
(50%), and Lysholm knee scores (50%). North American
countries varied the most in outcome scores used, which
included the SF-36 (71.4%), Modified Cincinnati Knee
Rating System (42.9%), KOOS (42.9%), IKDC (42.9%),
and Western Ontario and McMaster Universities Arthritis
Index (WOMAC) (28.6%). When evaluating the top 5 most
commonly used outcome scores listed for each country, the
only one that was significantly different in terms of utilization between the 4 global regions was the SF-36 (P < .001).

Failures of Cartilage Procedures by Region
Clinical failures in our systematic review were determined
by the criteria for each respective study, and this was
reported in 70% of European, 27% of Asian, 57% of North
American, and 0% of South American studies. The overall
failure rate and failure rate among specific procedural
groups are shown in Table 7, with North American countries showing the highest failure rate among the 3 global
regions (16.2%).

Discussion
Articular cartilage injuries in the knee are very common,
having been shown to be present in up to 66% of patients
undergoing knee arthroscopy, which means they will likely
be encountered by surgeons treating knee injuries.1-4
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Table 5. Anatomic Location of Chondral Defect.

Europe
Asia
North America
South America
Total

Femoral Condyle

Patellofemoral

Tibial Plateau

Total

3,324
336
388
53
4,101
P < 0.001

714
273
122
40
1,149
P < 0.001

53
24
0
14
91
P < 0.001

4,091
633
510
107
5,341

Table 6. Mechanism of Chondral Injury.

Europe
Asia
North America
South America

Traumatic

Degenerative

Osteochondritis Dissecans

71% (1,974/2,779)
10.3% (36/348)
58.1% (75/129)
NA

16.7% (464/2,779)
89.7% (312/348)
41.9% (54/129)
NA

12.3% (341/2,779)
NA
NA
NA

Table 7. Failure Rate of Cartilage Procedures by Region.
Overall
Europe
9.4% (261/2,762)
Asia
0% (0/108)
North America 16.2% (96/592)
South America
NA

Cartilage-Based

Microfracture

Osteochondral
Autograft/Mosaicplasty

7.1% (101/1,432)
0% (0/20)
16.2% (96/592)
NA

12.5% (114/912)
0% (0/24)
NA
NA

14.8% (40/271)
NA
NA
NA

Management of these injuries continues to evolve as new
technology is developed. Thus, it is not surprising that the
number of articular cartilage procedures performed in the
knee has grown at an annual rate of 5% from 2004 to 2011.11
Despite the rapid evolution of surgical techniques, the vast
majority of studies analyzing these procedures are of a
lower level of evidence (i.e., levels 3-5).10,11,14 As a result,
the optimal management of these lesions continues to be
debated. The debate may be influenced by global differences in the preference of one procedure over another,
which may be based on economic factors and/or lack of
access to grafts, for instance, in the Asian-Pacific region,
there are far fewer commercial tissue banks available as
compared with North America.17 In addition, it has been
shown that non-commercial tissue banks may have “processing costs” which may be charged to patients or institutions and could potentially limit the use of allograft tissue.17
Ethical cultural and religious factors must be taken into
consideration as well as some populations are more likely to
be accepting of tissue donation based on their beliefs which
could influence the regional variation in cartilage injury
treatment.13,17
This systematic review found that the majority of level 1
and 2 studies evaluating articular cartilage procedures of

Biologic

Experimental

0% (0/14)

6% (8/133)
0% (0/64)
NA
NA

NA

the knee have originated from European countries, with a
majority of these studies evaluating cell-based therapy and
marrow stimulation. Similarly, the majority of level 1 and 2
studies originating in North America predominantly
involved cell-based therapies. In contrast, the majority of
level 1 and 2 studies originating in Asian countries evaluated more experimental, biologic, and marrow-stimulation
procedures. There was also a significant difference in the
anatomic location of chondral lesions between studies
across the 4 global regions. Differences were also noted in
sex and age distribution, with a higher proportion of females
and older patients included in studies from Asian countries.
This finding should be considered when assessing potential
articular cartilage treatments as both older age and female
sex have been shown to negatively influence outcomes following articular cartilage surgery.15,20
Although the mechanism of chondral injury was poorly
reported across all 4 global regions, a difference was found
between all regions reporting them, with a higher number of
degenerative cases being reported in Asian countries and
while the majority of European studies reported the treatment of OCD lesions. Differences in injury mechanism may
play a role in the treatment of these injuries as degenerative
lesions are more likely in an older patient population
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whereas traumatic and OCD lesions are most commonly
seen in younger patients; therefore, this information can be
beneficial for physicians treating specific patient populations with cartilage injuries. For example, if treating an
older patient with degenerative cartilage lesions, studies
from Asian countries may be more applicable, whereas
younger patients with traumatic or OCD lesions fit the
patient profile of European and/or North American studies.
Future studies should report the mechanism of cartilage
injury as this may be important information when assessing
and comparing outcomes. No differences were seen in the
length of follow-up, BMI, cartilage lesion size, or location.
However, overall failure rate was higher in North American
countries when compared with other countries.
Although there have been no studies, to our knowledge,
evaluating articular cartilage management based on geographic location, other studies have shown regional differences in various orthopedic procedures.16,21-27 Although not
specifically looking at regional differences, there have been
studies which evaluated trends in cartilage-based procedures in the United States.11,14,24 In the United States, microfracture and chondroplasty are the most common treatment
for chondral injuries, especially in middle-aged patients,
while osteochondral autograft/allograft and autologous
chondrocyte implantation (ACI) are more common in
younger patients.24 Since 2003 in the United States, there
has been a paradigm shift in favor of more complex articular cartilage procedures being performed compared with
less complicated marrow-stimulation procedures based on
the surgical practice of American Board of Orthopaedic
Surgery (ABOS) Part II candidates.14
There are limitations to this study, which should be mentioned. There was inconsistent reporting of all variables in
the studies included from the 4 global regions, which could
have influenced the outcomes evaluated. In addition, the
number of studies from each region varied widely, which
makes comparison between the regions difficult and could
confound outcomes of this review. Although we included
searches in all languages, it is possible that some studies
could have been overlooked if they were not included in our
database searches. Although the data extraction was not
performed in a blinded fashion, 2 independent reviewers
reviewed and extracted the data which was then verified by
the first author and no discrepancies needed to be resolved
by a third author. In addition, several patients in the various
studies underwent concomitant procedures which was difficult to control for when evaluating the outcomes of interest; however, it is possible these concomitant procedures
could affect the outcomes of cartilage-based procedures.
We did not investigate the correlation between patient and/
or defect characteristics and the choice of technique nor
compare outcomes between reparative, such as bone marrow stimulating techniques, and restorative methods, such
as cell- or tissue-based treatments. Finally, the mere fact
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that certain procedures were more common in each global
region does not necessarily imply that those same procedures are performed preferentially by the majority of surgeons in that region. It is unclear to what extent clinical
studies evaluating a particular surgical procedure from a
region represent a proxy for the total number of procedures
performed in that region.
This systematic review of level 1 and 2 studies evaluating
articular cartilage procedures for the knee found that the
majority of studies come from European countries followed
by Asian countries, North American countries, and South
American countries, respectively. European and North
American countries included more cell-based and marrowstimulation procedures, whereas Asian countries exhibited a
higher proportion of experimental, biologic, and marrowstimulation procedures. There were geographic differences in
the anatomic location of the chondral injuries, mechanism of
injury, patient age and sex distribution in the studies originating in the 4 global regions with studies from Asian countries
reporting a higher proportion of older patients and female
patients. While the cause of these differences is unclear, these
global differences should be considered when interpreting
studies of articular cartilage surgery in the knee and using
them to guide treatment of specific patient populations.
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